Intralipid therapy for recurrent implantation failure: new hope or false dawn?
Authors:
- N. ShreeveNSN. Shreeve
- K. SadekKSK. Sadek
- 1 January 2012
- journal article
- Published by Elsevier in Journal of Reproductive Immunology
- Vol. 93 (1) , 38-40
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Regulatory T cells and inhibitory cytokines in autoimmunityCurrent Opinion in Immunology, 2009
- Development and function of TH17 cells in health and diseaseJournal of Allergy and Clinical Immunology, 2009
- Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment?Human Reproduction Update, 2009
- ORIGINAL ARTICLE: Serial Estimation of Th1:Th2 Cytokines Profile in Women Undergoing In‐Vitro Fertilization‐Embryo TransferAmerican Journal of Reproductive Immunology, 2008
- Impact of postoperative omega-3 fatty acid-supplemented parenteral nutrition on clinical outcomes and immunomodulations in colorectal cancer patientsWorld Journal of Gastroenterology, 2008
- The Th1/Th2 paradigm: still important in pregnancy?Seminars in Immunopathology, 2007
- Phenotypic characterization of regulatory T cells in the human deciduaClinical and Experimental Immunology, 2004
- Effects of Parenteral Lipid Emulsions With Different Fatty Acid Composition on Immune Cell Functions In VitroJournal of Parenteral and Enteral Nutrition, 2000
- Intralipid as Treatment for Recurrent Unexplained Abortion?American Journal of Reproductive Immunology, 1994
- The optical properties of aqueous suspensions of Intralipid, a fat emulsionPhysics in Medicine & Biology, 1989